In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vascular Interventional Devices: New Avenues For Growth

Executive Summary

Manufacturers are finding it harder to innovate in the vascular interventional devices as market and regulatory pressures take their toll. New coronary drug-eluting stents face a difficult challenge with the high bar now set by existing devices, and there have been several recent disappointments in renal denervation, drug-coated balloons, and renal artery stenting; still there are some promising areas, with bioresorbable stents offering perhaps the best prospect among vascular therapies for future blockbuster status.

Advertisement

Related Content

US Cardiovascular Sector In Need Of A Jolt From First-of-A-Kind Balloons And Stents
After Atherectomy: Shockwave Medical Preps For Success
Medtech 2013: Device Companies Go Where The Growth Is
SYMPLICITY Results Make Life Difficult For Renal Denervation Programs
Renal Denervation Downer: Medtronic’s Pivotal Trial Misses Efficacy Endpoint
Medtronic Recall Raises Red Flag For DCBs Below The Knee
Reinvigorating The Coronary Stent Market: Can Bioresorbable Scaffolds Do The Job?
Device Trends To Watch In 2013
Drug-Coated Balloons Fuel Multibillion-Dollar Hopes
Renal Denervation Sparks Device Market Gold Rush

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004189

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel